วันเสาร์ที่ ๓๐ พฤษภาคม พ.ศ. ๒๕๕๘ ๐๕:๑๗ น.
Food and Healthcare Press Releases
PTT Exploration and Production Public Company Limited (PTTEP) represented by Vinit Hansamuit, Senior Vice President for International Asset Division, and Titi Thongjen, Vice President, Indonesia Asset, together with Parni Hadi, Chairman of Board of
Enriched Deep Ocean Minerals (DOM(R)) were launched for the first time in Vietnam to the food ingredient industry at the Fi Vietnam tradeshow, with Pacific Deep Ocean Biotech Co Ltd determined to make its DOM(R) trademark a household name in Asian Nutrition. Already launched in Taiwan, mainland China, Japan, and Australia, over the next six months the company will continue to strategically launch, with Hong Kong next followed by Thailand, Indonesia and India.
Mr. Harry Chai, Global Business Development Manager, commented, "Vietnamese companies embraced our standardized, enriched Deep Ocean Mineral ingredients with unprecedented enthusiasm. The rapidly expanding Vietnamese nutrition and supplement industry saw immediate application for our DOM(R) products in the sports performance and cholesterol control segments."
Pacific Deep Ocean Biotech attended the Food ingredients (Fi) Trade Show, May 20-22 at the Saigon Exhibition and Convention Center, in Ho Chi Minh City, Vietnam. Fi Vietnam is an event attended by progressive food companies seeking new and innovative ingredients to add nutrition to their food and beverage products.
- Global collaboration to extend the portfolio of Merck Serono, a leading company in fertility treatment, in the growing market of fertility technologies to support standardization and improve fertility outcomes - Merck receives global marketing and
A special presentation at Digestive Disease Week 2015 featured GERD experts weighing in on their successful experience using Stretta Therapy to treat challenging patient populations suffering from GERD. Infographic -
ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval, to the Food and Drug
Merck Serono, the biopharmaceutical business of Merck, today announced the support of 7th International Thyroid Awareness Week (ITAW). This year´s campaign launched today for ITAW is aimed at alerting millions of people across the world that they
Merck Serono, the biopharmaceutical business of Merck, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on an update to the product information for its product
ASCO Abstract # Avelumab*: 3023, 3044, 3055, TPS9086, TPS3101, 4042, 4047, 5509, 8034; evofosfamide: TPS9089, 8579; tepotinib: 2591; tecemotide[†]: 3036. - New data on priority candidates from Merck's oncology and immuno-oncology pipeline are
Dr. Jonathan Yarom, Herbalife Nutrition Advisory Board (NAB) member, delivers an inspiring talk on achieving good health, fitness and well-being to over 500 health enthusiasts in Thailand. Herbalife, a global nutrition company, recently organized the
Masimo (NASDAQ: MASI) announced today a study published in the Journal of the American College of Surgeons found that implementing a multidisciplinary perioperative Enhanced Recovery protocol that included intraoperative fluid management guided by a
-- 18,000 Stretta procedures performed since introduction, making Stretta the safest and most widely used endoluminal therapy for GERD -- Stretta expands reach with regulatory approvals added in large international markets Mederi Therapeutics Inc.
- Safety Signal of Increased Cardiovascular Mortality Found For ASV Therapy In People With Predominant Central Sleep Apnea and Symptomatic Chronic Heart Failure - Results and Safety Signal Observed Only In This Specific Study Population ResMed (NYSE:
- Advanced pancreatic cancer is second indication to receive FDA fast track designation for evofosfamide Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced
Cycling seems to have taken Thailand by storm, with the number of amateur and recreational bikers on the rise over the last few years. On the streets of Bangkok, more and more bikers have been appearing, especially with the introduction of pun-pun, the
More than 4,000 Thai cancer patients have benefitted from a Novartis patient programme that is designed to support the needs of patients that cannot afford the medicines required for two specific cancers. At the 12th anniversary of the formation of the
Evidera , a leading provider of evidence-based solutions for the healthcare industry, is pleased to announce the release of the European Medicines Agency's (EMA) draft qualification opinion on the EXACT (Exacerbations of Chronic Pulmonary Tool) and E-RS
IPMI provider Now Health International (http://nowhealth-bestdoctors.com) today confirms that their investor, The Primary Group, subject to relevant approvals, has reached an agreement to acquire Best Doctors Insurance, a major medical insurance
Today, Neusoft Medical Systems Co., Ltd. ("Neusoft Medical Systems") officially launched the NeuViz 128 CT for the global markets, and the new products are being exported to South Asia, North Africa and other international markets. Neusoft Medical
Since 2011, ArKay Has Been Very Successful as the World's First Soft Drink That Replicates Alcohol, Providing the Placebo Effect for People on Medication. ArKay is inviting our Muslim friends to be part of our success. ArKay has created a new collection
WIENER NEUSTADT, Austria, SALZBURG, Austria and REUTLINGEN, Germany--8 May--PRNewswire/InfoQuest An innovative system for accurate patient positioning already received attention at its market launch in 2014. Now the first of these systems has been
First programme to evaluate dual HIV maintenance therapy with dolutegravir and rilpivirine ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay(R)) and rilpivirine
For the first time in freediving history, Masimo (NASDAQ: MASI), maker of breakthrough Measure-through Motion and Low Perfusion(TM) pulse oximetry, has equipped the Suunto Vertical Blue freediving competition with consumer versions of MightySat(R)
Other cafe franchises may ask you to invest as much as $250,000 and pay upfront fees to open a coffee shop. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=32487 ArKay Social Cafe is the best
Molecular Health announced today it has been granted a patent in Europe entitled "Tissue Protective Erythropoietin Receptor". This latest patent supports Molecular Health's discovery that EPHB4 is a novel receptor for Erythropoietin (EPO), where EPHB4